138 related articles for article (PubMed ID: 10458426)
1. Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children.
Furness PD; Maizels M; Han SW; Cohn RA; Cheng EY
J Urol; 1999 Sep; 162(3 Pt 2):1033-6. PubMed ID: 10458426
[TBL] [Abstract][Full Text] [Related]
2. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children.
El-Sherbiny MT; Mousa OM; Shokeir AA; Ghoneim MA
J Urol; 2002 Oct; 168(4 Pt 2):1798-800. PubMed ID: 12352362
[TBL] [Abstract][Full Text] [Related]
3. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction.
Liatsikos EN; Dinlenc CZ; Bernardo NO; Kapoor R; Jabbour ME; Smith AD; Kushner L
J Endourol; 2001 Aug; 15(6):567-70. PubMed ID: 11552777
[TBL] [Abstract][Full Text] [Related]
4. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY
Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up.
Sager C; Lopez JC; Duran V; Burek C; Perazzo E
Int Braz J Urol; 2009; 35(3):315-23; discussion 323-5. PubMed ID: 19538767
[TBL] [Abstract][Full Text] [Related]
6. The role of bladder urine transforming growth factor-beta1 concentrations in diagnosis and management of unilateral prenatal hydronephrosis.
Almodhen F; Loutochin O; Capolicchio JP; Jednak R; El-Sherbiny M
J Urol; 2009 Jul; 182(1):292-8; discussion 298. PubMed ID: 19450826
[TBL] [Abstract][Full Text] [Related]
7. Urinary transforming growth factor-beta1 levels correlate with bladder outlet obstruction.
Monga M; Gabal-Shehab LL; Stein P
Int J Urol; 2001 Sep; 8(9):487-9. PubMed ID: 11683968
[TBL] [Abstract][Full Text] [Related]
8. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
[TBL] [Abstract][Full Text] [Related]
9. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
BJU Int; 2007 Apr; 99(4):899-903. PubMed ID: 17378848
[TBL] [Abstract][Full Text] [Related]
10. Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction.
Li ZZ; Zhao ZZ; Wen JG; Xing L; Zhang H; Zhang Y
J Pediatr Surg; 2012 Aug; 47(8):1581-6. PubMed ID: 22901921
[TBL] [Abstract][Full Text] [Related]
11. Changes in detrusor and urinary growth factors according to detrusor function after partial bladder outlet obstruction in the rat.
Chul Kim J; Il Seo S; Hyun Park Y; Kon Hwang TA
Urology; 2001 Feb; 57(2):371-5. PubMed ID: 11182367
[TBL] [Abstract][Full Text] [Related]
12. Urinary transforming growth factor-β1 in children with obstructive uropathy.
Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.
MacRae Dell K; Hoffman BB; Leonard MB; Ziyadeh FN; Schulman SL
Urology; 2000 Aug; 56(2):311-4. PubMed ID: 10925100
[TBL] [Abstract][Full Text] [Related]
14. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
[TBL] [Abstract][Full Text] [Related]
15. The role of renal biomarkers to predict the need of surgery in congenital urinary tract obstruction in infants.
Kostic D; Beozzo GPNS; do Couto SB; Kato AHT; Lima L; Palmeira P; Krebs VLJ; Bunduki V; Francisco RPV; Zugaib M; Dénes FT; de Carvalho WB; Koch VHK
J Pediatr Urol; 2019 May; 15(3):242.e1-242.e9. PubMed ID: 30979613
[TBL] [Abstract][Full Text] [Related]
16. [Microproteinuria as a marker of renal damage in children].
Chiaramonte C; Cigna RM; Cataliotti F
Minerva Urol Nefrol; 2002 Dec; 54(4):237-42. PubMed ID: 12536194
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology.
Eissa S; Salem AM; Zohny SF; Hegazy MG
Cancer Biomark; 2007; 3(6):275-85. PubMed ID: 18048965
[TBL] [Abstract][Full Text] [Related]
18. Association of urinary transforming growth factor-β1 with the ureteropelvic junction obstruction.
Merrikhi A; Bahraminia E
Adv Biomed Res; 2014; 3():123. PubMed ID: 24949294
[TBL] [Abstract][Full Text] [Related]
19. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
Cost NG; Noh PH; Devarajan P; Ivancic V; Reddy PP; Minevich E; Bennett M; Haffner C; Schulte M; DeFoor WR
J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
[TBL] [Abstract][Full Text] [Related]
20. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
